<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Post-ischemic <z:mp ids='MP_0003674'>oxidative stress</z:mp> and vasomotor dysfunction in cerebral arteries may increase the likelihood of <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> and secondary <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the underlying mechanisms of post-<z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0002597'>vascular abnormalities</z:hpo>, as distinct from those causing primary brain injury, are poorly understood </plain></SENT>
<SENT sid="2" pm="."><plain>We tested whether augmented <z:chebi fb="1" ids="18421">superoxide</z:chebi>-dependent dysfunction occurs in the mouse cerebral circulation following <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion, and evaluated the role of Nox2 oxidase </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: <z:hpo ids='HP_0002637'>Cerebral ischemia</z:hpo> was induced in male C57Bl6/J <z:mp ids='MP_0002169'>wild-type</z:mp> (WT) and Nox2-deficient (Nox2(-/-)) mice by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO; 0.5 h), followed by reperfusion (23.5 h) </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="1" ids="18421">Superoxide</z:chebi> production by <z:chebi fb="70" ids="34342">MCA</z:chebi> was measured by L-012-enhanced chemiluminescence </plain></SENT>
<SENT sid="5" pm="."><plain>Nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO) function was assessed in cannulated and pressurized <z:chebi fb="70" ids="34342">MCA</z:chebi> via the vasoconstrictor response to N(ω)-<z:chebi fb="13" ids="29785">nitro</z:chebi>-<z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> <z:chebi fb="36" ids="29309">methyl</z:chebi> <z:chebi fb="21" ids="35701">ester</z:chebi> (L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e>; 100 µmol/L) </plain></SENT>
<SENT sid="6" pm="."><plain>Expression of Nox2, the nitration marker 3-nitrotyrosine, and leukocyte marker CD45 was assessed in cerebral arteries by Western blotting </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Following <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion, <z:chebi fb="1" ids="18421">superoxide</z:chebi> production was markedly increased in the <z:chebi fb="70" ids="34342">MCA</z:chebi> of WT, but not Nox2(-/-) mice </plain></SENT>
<SENT sid="8" pm="."><plain>In WT mice, L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e>-induced constriction was reduced by ∼50% in ischemic <z:chebi fb="70" ids="34342">MCA</z:chebi>, whereas <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion had no effect on responses to L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e> in vessels from Nox2(-/-) mice </plain></SENT>
<SENT sid="9" pm="."><plain>In ischemic <z:chebi fb="70" ids="34342">MCA</z:chebi> from WT mice, expression of Nox2 and 3-nitrotyrosine were ∼1.4-fold higher than in the contralateral <z:chebi fb="70" ids="34342">MCA</z:chebi>, or in ischemic or contralateral vessels from Nox2(-/-) mice </plain></SENT>
<SENT sid="10" pm="."><plain>Vascular CD45 levels were unchanged by <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Excessive <z:chebi fb="1" ids="18421">superoxide</z:chebi> production, impaired NO function and nitrosative stress occur in mouse cerebral arteries after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion </plain></SENT>
<SENT sid="12" pm="."><plain>These abnormalities appear to be exclusively due to increased activity of vascular Nox2 oxidase </plain></SENT>
</text></document>